🚀 VC round data is live in beta, check it out!
Vitaminka Valuation Multiples
Discover revenue and EBITDA valuation multiples for Vitaminka and similar public comparables like Natural Alternatives International, KKO International, Seko, Excellence and more.
Vitaminka Overview
About Vitaminka
Vitaminka AD manufactures pasteurized and sterilized products. Its product offerings include marmalades, jams, ajvar, beetroot, cucumber, paprika fillet, mixed salad, pepperoni, fruit juices, nectars and fruit syrups.
Founded
1974
HQ
Employees
682
Website
Sectors
Financials (FY)
EV
$47M
Vitaminka Financials
Vitaminka reported last fiscal year revenue of $66M and EBITDA of $6M.
In the same fiscal year, Vitaminka generated $22M in gross profit, $6M in EBITDA, and $2M in net income.
Vitaminka P&L
In the most recent fiscal year, Vitaminka reported revenue of $66M and EBITDA of $6M.
Vitaminka expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $66M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $22M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 34% | XXX | XXX | XXX |
| EBITDA | — | XXX | $6M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 9% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 5% | XXX | XXX | XXX |
| Net Profit | — | XXX | $2M | XXX | XXX | XXX |
| Net Margin | — | XXX | 3% | XXX | XXX | XXX |
| Net Debt | — | — | $11M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Vitaminka Stock Performance
Vitaminka has current market cap of $18M, and enterprise value of $47M.
Market Cap Evolution
Vitaminka's stock price is $235.72.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $47M | $18M | 0.3% | XXX | XXX | XXX | $22.85 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialVitaminka Valuation Multiples
Vitaminka trades at 0.7x EV/Revenue multiple, and 7.8x EV/EBITDA.
Vitaminka Financial Valuation Multiples
As of March 19, 2026, Vitaminka has market cap of $18M and EV of $47M.
Equity research analysts estimate Vitaminka's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Vitaminka has a P/E ratio of 10.3x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $18M | XXX | $18M | XXX | XXX | XXX |
| EV (current) | $47M | XXX | $47M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 0.7x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 7.8x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 15.7x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 2.1x | XXX | XXX | XXX |
| P/E | — | XXX | 10.3x | XXX | XXX | XXX |
| EV/FCF | — | XXX | (70.1x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Vitaminka Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Vitaminka Margins & Growth Rates
Vitaminka's revenue in the last fiscal year grew by 8%.
Vitaminka Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 8% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 9% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 1% | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 3% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 1% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 29% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Vitaminka Public Comps
See public comps and valuation multiples for other Food & Beverages comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Natural Alternatives International | XXX | XXX | XXX | XXX | XXX | XXX |
| KKO International | XXX | XXX | XXX | XXX | XXX | XXX |
| Seko | XXX | XXX | XXX | XXX | XXX | XXX |
| Excellence | XXX | XXX | XXX | XXX | XXX | XXX |
| Bio Planet | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Vitaminka M&A Activity
Vitaminka acquired XXX companies to date.
Last acquisition by Vitaminka was on XXXXXXXX, XXXXX. Vitaminka acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Vitaminka
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialVitaminka Investment Activity
Vitaminka invested in XXX companies to date.
Vitaminka made its latest investment on XXXXXXXX, XXXXX. Vitaminka invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Vitaminka
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Vitaminka
| When was Vitaminka founded? | Vitaminka was founded in 1974. |
| Where is Vitaminka headquartered? | Vitaminka is headquartered in Bosnia and Herzegovina. |
| How many employees does Vitaminka have? | As of today, Vitaminka has over 682 employees. |
| Is Vitaminka publicly listed? | Yes, Vitaminka is a public company listed on Macedonian Stock Exchange. |
| What is the stock symbol of Vitaminka? | Vitaminka trades under VITA ticker. |
| Who are competitors of Vitaminka? | Vitaminka main competitors are Natural Alternatives International, KKO International, Seko, Excellence. |
| What is the current market cap of Vitaminka? | Vitaminka's current market cap is $18M. |
| What is the current revenue of Vitaminka? | Vitaminka's last fiscal year revenue is $66M. |
| What is the current EV/Revenue multiple of Vitaminka? | Current revenue multiple of Vitaminka is 0.7x. |
| Is Vitaminka profitable? | No, Vitaminka is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.